Snohomish, WA, United States of America

Brian Robert Kovacevich

USPTO Granted Patents = 65 

 

 

Average Co-Inventor Count = 8.5

ph-index = 17

Forward Citations = 973(Granted Patents)

Forward Citations (Not Self Cited) = 745(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Renton, WA (US) (2002 - 2017)
  • Redmond, WA (US) (2020)
  • Bellevue, WA (US) (2021)
  • Snohomish, WA (US) (2011 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bispecific Tetravalent Antibodies
Multi-Specific Antibodies
Anti-IL-6 Antibodies
Anti-CGRP Antibodies
Anti-PD-1 Antibodies
Anti-NGF Compositions
Guidance and Navigation Control Proteins
Anti-4-1BB Antibodies
Anti-PCSK9 Antibodies
Autoimmunity Treatment
Photophobia Treatment
Bone Mineralization
65 patents (USPTO):Explore Patents

Title: Brian Robert Kovacevich: Innovator in Guidance and Navigation Control Protein Technologies

Introduction

Brian Robert Kovacevich, based in Snohomish, WA, is a prolific inventor with an impressive portfolio of 52 patents. His work primarily focuses on advancements in biotechnology, particularly in the realms of guidance and navigation control proteins which play a crucial role in immunotherapy and cancer treatment.

Latest Patents

Kovacevich's recent patents include groundbreaking technologies such as "Guidance and Navigation Control proteins and method of making and using thereof." This patent describes GNC proteins that include various binding domains for key T cell receptors and tumor associated antigens, optimizing immune responses against cancer. Another significant patent is "Anti-4-1BB antibodies and methods of making and using thereof," which covers monoclonal antibodies designed to enhance T-cell functionality in combating cancers and other disorders linked to T-cell dysfunction.

Career Highlights

Throughout his career, Brian has collaborated with innovative companies such as Alderbio Holdings LLC and Systimmune, Inc., furthering research and development in his field. His contributions bring forth new possibilities in the treatment of malignancies and immune challenges, showcasing his dedication to enhancing therapeutic strategies.

Collaborations

Brian’s innovative journey has been facilitated by partnerships with notable professionals including Leon F Garcia-Martinez and John A Latham. These collaborations have enriched his research, combining diverse expertise to tackle complex biomedical challenges.

Conclusion

In conclusion, Brian Robert Kovacevich stands out as a significant figure in the world of biotechnology innovation. His extensive patent portfolio and collaborative efforts position him at the forefront of medical advancements, making valuable contributions to the treatment of cancer and immune disorders. His ongoing work is poised to inspire further innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…